Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50513, first published .
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Evan L Fogel   1 , MSc, MD ;   Jeffrey J Easler   1 , MD ;   Ying Yuan   2 , PhD ;   Dhiraj Yadav   3 , MPH, MD ;   Darwin L Conwell   3 , MSc, MD ;   Santhi Swaroop Vege   4 , MD ;   Samuel Y Han   5 , MS, MD ;   Walter Park   6 , MD ;   Vanessa Patrick   1 , RN ;   Fletcher A White   7 , MSc, PhD

1 Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, United States

2 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

3 Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

4 Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States

5 Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States

6 Department of Medicine, Stanford University Medical Center, Stanford, CA, United States

7 Department of Anesthesia, School of Medicine, Indiana University, Indianapolis, IN, United States

Corresponding Author:

  • Evan L Fogel, MSc, MD
  • Department of Medicine
  • School of Medicine
  • Indiana University
  • Suite 1602
  • 550 N. University Blvd
  • Indianapolis, IN, 46202
  • United States
  • Phone: 1 317 274 8157
  • Email: efogel@iu.edu